Back to top

H.C. Wainwright Sticks to Their Hold Rating for Sutro Biopharma (STRO)

H.C. Wainwright analyst Andres Y. Maldonado maintained a Hold rating on Sutro Biopharma today and set a price target of $2.00. The company’s shares...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sutro Biopharma, Inc. (STRO)